Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does treatment with antibodies to tumor necrosis factor cause serious infections and malignancies?

Nature Clinical Practice Rheumatology volume 2, pages 584–585 (2006)Cite this article

Access through your institution
Buy or subscribe

boxed-textBongartz T et al. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. Systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295: 2275–2285

Background

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Askling J et al. (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64: 1414–1420

    Article  CAS  Google Scholar 

  2. Maury EE et al. (2005) Rheumatoid arthritis (RA) patients on tumor necrosis factor (TNF) blockers do not have an increased risk of cancer [abstract F6]. American College of Rheumatology Annual Scientific Meeting 2005, November 13–17, San Diego, CA, USA

    Google Scholar 

  3. Askling J et al. (2005) Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis 64: 1421–1426

    Article  CAS  Google Scholar 

  4. Franklin JP et al. (2005). Risk of lymphoma in patients with RA treated with anti-TNFα agents. Ann Rheum Dis 64: 657–658

    Article  CAS  Google Scholar 

  5. Baecklund E et al. (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54: 692–701

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor and the Head of the Department of Rheumatology at the Erasmus University Medical Center, Rotterdam, The Netherlands

    J Mieke Hazes

Authors
  1. J Mieke Hazes
    View author publications

    Search author on:PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hazes, J. Does treatment with antibodies to tumor necrosis factor cause serious infections and malignancies?. Nat Rev Rheumatol 2, 584–585 (2006). https://doi.org/10.1038/ncprheum0344

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncprheum0344

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing